Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial.
Publication
, Journal Article
Butler, J; Anstrom, KJ; Armstrong, PW
Published in: Circulation
August 25, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
August 25, 2020
Volume
142
Issue
8
Start / End Page
717 / 719
Location
United States
Related Subject Headings
- Pyrimidines
- Multicenter Studies as Topic
- Humans
- Heterocyclic Compounds, 2-Ring
- Heart Failure
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Butler, J., Anstrom, K. J., & Armstrong, P. W. (2020). Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial. Circulation, 142(8), 717–719. https://doi.org/10.1161/CIRCULATIONAHA.120.047086
Butler, Javed, Kevin J. Anstrom, and Paul W. Armstrong. “Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial.” Circulation 142, no. 8 (August 25, 2020): 717–19. https://doi.org/10.1161/CIRCULATIONAHA.120.047086.
Butler J, Anstrom KJ, Armstrong PW. Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial. Circulation. 2020 Aug 25;142(8):717–9.
Butler, Javed, et al. “Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial.” Circulation, vol. 142, no. 8, Aug. 2020, pp. 717–19. Pubmed, doi:10.1161/CIRCULATIONAHA.120.047086.
Butler J, Anstrom KJ, Armstrong PW. Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial. Circulation. 2020 Aug 25;142(8):717–719.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
August 25, 2020
Volume
142
Issue
8
Start / End Page
717 / 719
Location
United States
Related Subject Headings
- Pyrimidines
- Multicenter Studies as Topic
- Humans
- Heterocyclic Compounds, 2-Ring
- Heart Failure
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology